MedPath

Effect of topical solution of Cetirizine on Androgenetic Alopecia

Phase 3
Recruiting
Conditions
Androgenetic alopecia.
Androgenic alopecia
Registration Number
IRCT20161207031288N3
Lead Sponsor
Center of research and training in skin diseases and leprosy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
40
Inclusion Criteria

Males st the age of 18 to 49 years
Male pattern hair-loss should be at 2,3,4 in Norwood Scale
Signed informed consent voluntarily and knowingly

Exclusion Criteria

History of allergy to Cetirizine or Minoxidil
Using 5-alpha reductase inhibitor in the last year
Using Isotretinion over the past year
Using nutritional supplement and herbal remedies for hair growth in the last 3 months
Chemotherapy in the last year
Scalp has been exposed to radiation in the past year
History of uncontrolled Blood Pressure
History of Hypotention
Taking systemic Steroid for more than 14 days in the last 2 months

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hair count. Timepoint: Before intervention , two months later, 4 months later. Method of measurement: fotofinder trichoscale.;Hair density. Timepoint: Before intervention , two months later, 4 months later. Method of measurement: fotofinder trichoscale.
Secondary Outcome Measures
NameTimeMethod
Anagen -telogen hair percantage. Timepoint: Before intervention , two months later, 4 months later. Method of measurement: fotofinder trichoscale.;Number and density of vellus hair to terminal hair. Timepoint: Before intervention , two months later, 4 months later. Method of measurement: fotofinder trichoscale.
© Copyright 2025. All Rights Reserved by MedPath